Angios FlexCo hat dies direkt geteilt
Angios FlexCo
Biotechnologieforschung
Innsbruck, Tyrol 623 Follower:innen
Novel approaches to vascular therapy
Info
Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new treatments for challenging diabetic vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by leveraging the vascular organoid model developed in the laboratories of our founders.
- Website
-
http://www.angios-bio.com
Externer Link zu Angios FlexCo
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Innsbruck, Tyrol
- Art
- Privatunternehmen
- Gegründet
- 2021
- Spezialgebiete
- Diabetes, Blood vessels, Organoids und Diabetic Retinopathy
Orte
-
Primär
Wegbeschreibung
Exlgasse 20a
Innsbruck, Tyrol 6020, AT
Beschäftigte von Angios FlexCo
-
Azarakhsh Oladzad
Senior Scientist
-
Tanila Ben Haddou
Scientist & Lab Manager @ Angios GmbH | Ph.D. in Pharmaceutical Sciences & B.A. (MCI) in Business Administration | Digital Marketing enthusiast
-
Nicole Przysiecki
Biotechnologin
-
Gregor Wick
CEO & Founder bei Angios Flexco, Consultant to Life Sciences companies
Updates
-
Great to be part of this Horizon project
Angios with partners from SWEEPICS consortium in our kick-off meeting in Lübeck. Check us out at www.sweepics.eu
-
-
Angios with partners from SWEEPICS consortium in our kick-off meeting in Lübeck. Check us out at www.sweepics.eu
-
-
We are hiring! Check out the position on our website www.angios-bio.com
-
Read about Angios as one of several Spin-Offs from IMBA on the website of the Austrian Academy of Sciences. „Forschung trifft Anwendung“
Ein Spin-off sagt Diabetes den Kampf an
oeaw.ac.at
-
In this week’s issue of Austrian magazine profil there is an excellent article about organoid research at IMBA. Watch out for the interview with Angios‘ Head of R&D Teodor Yordanov „Lebensadern“ speaking about how we at Angios strive to develop cell therapy for non healing wounds, replacement of animal testing by vascular organoids and the potential for vascularisation in general Congratulations team!
-